RADIANT-3 Trial: Everolimus in Pancreatic Neuroendocrine Tumors
0 Views
administrator
07/08/23
Jonathan Strosberg, MD, Diane Reidy-Lagunes, MD, MS, and Rodney F. Pommier, MD, discuss results from the phase III RADIANT-3 trial that explored everolimus in patients with pancreatic neuroendocrine tumors.
For more from this discussion, visit http://www.onclive.com/peer-ex....change/pancreatic-ne
-
Category
Show more
Facebook Comments
No comments found